4//SEC Filing
Myles David C. 4
Accession 0001415889-23-015041
CIK 0001750284other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:30 PM ET
Size
6.9 KB
Accession
0001415889-23-015041
Insider Transaction Report
Form 4
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
Transactions
- Sale
Common Stock
2023-11-08$17.61/sh−200$3,522→ 561,270 total
Holdings
- 12,831(indirect: See Footnote)
Common Stock
- 154,846(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person dated June 20, 2023.
- [F2]The weighted average sale price for the transaction reported was $17.61, and the range of prices were between $17.52 and $17.69. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares are held by The Myles Family Revocable Inter Vivos Trust, of which the Reporting Person is trustee.
- [F4]The shares are held by Myles Properties Inc., of which the Reporting Person is President.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831216
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:30 PM ET
- Size
- 6.9 KB